Live Breaking News & Updates on Grfs

Stay updated with breaking news from Grfs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Grifols, S.A. (NASDAQ:GRFS) Given Consensus Rating of "Hold" by Analysts

Grifols, S.A. (NASDAQ:GRFS – Get Free Report) has been assigned a consensus rating of “Hold” from the six analysts that are presently covering the firm, MarketBeat Ratings reports. Four investment analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average twelve-month price target among […] ....

Nova Scotia , United States , Vistaseal Veraseal , Albutein Flexbag , Morgan Stanley , Raymond James Associates , Grifols Company Profile , Blackrock Inc , Financial Services Group Inc , Advisor Group Holdings Inc , Us Bancorp , Get Free Report , Marketbeat Ratings , Group Holdings , Services Group , Get Free , Gamunexc Immune Globulin Injection , Flebogamma Immune Globulin Intravenous , Xembify Immune Globulin Subcutaneous , Immune Globulin , Lynspad Alpha , Proteinase Inhibitor , Human Albumin , Plasbumin Albumin , Grifols Daily , Nasdaq Grfs ,

Grifols (NASDAQ:GRFS) Cut to Equal Weight at Morgan Stanley

Morgan Stanley lowered shares of Grifols (NASDAQ:GRFS – Free Report) from an overweight rating to an equal weight rating in a research report released on Tuesday, FlyOnTheWall reports. Separately, StockNews.com started coverage on shares of Grifols in a research note on Thursday, August 17th. They set a hold rating on the stock. Five investment analysts […] ....

United States , Albutein Flexbag , Vistaseal Veraseal , Morgan Stanley , Quadrant Capital Group , Financial Services Group Inc , Free Report , Get Free Report , Financial Advisors , Capital Group , Services Group , Gamunexc Immune Globulin Injection , Flebogamma Immune Globulin Intravenous , Xembify Immune Globulin Subcutaneous , Immune Globulin , Lynspad Alpha , Proteinase Inhibitor , Human Albumin , Plasbumin Albumin , Grifols Daily , Nasdaq Grfs ,

Morgan Stanley Lowers Grifols (NASDAQ:GRFS) to Equal Weight

Morgan Stanley lowered shares of Grifols (NASDAQ:GRFS – Free Report) from an overweight rating to an equal weight rating in a report published on Tuesday morning, FlyOnTheWall reports. Separately, StockNews.com began coverage on Grifols in a research report on Thursday, August 17th. They set a hold rating for the company. Five investment analysts have rated […] ....

United States , Albutein Flexbag , Vistaseal Veraseal , Financial Services Group Inc , Morgan Stanley , Quadrant Capital Group , Grifols Company Profile , Free Report , Get Free Report , Financial Advisors , Capital Group , Services Group , Gamunexc Immune Globulin Injection , Flebogamma Immune Globulin Intravenous , Xembify Immune Globulin Subcutaneous , Immune Globulin , Lynspad Alpha , Proteinase Inhibitor , Human Albumin , Plasbumin Albumin , Grifols Daily , Nasdaq Grfs ,

Grifols, S.A. (NASDAQ:GRFS) Receives $10.58 Consensus Price Target from Brokerages

Shares of Grifols, S.A. (NASDAQ:GRFS – Get Free Report) have earned an average rating of “Moderate Buy” from the six research firms that are presently covering the company, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 12 […] ....

United States , Vistaseal Veraseal , Albutein Flexbag , Grifols Company Profile , Goldman Sachs Group Inc , Wells Fargo Company , Orion Portfolio Solutions , Get Free Report , Marketbeat Ratings , Portfolio Solutions , Goldman Sachs Group , Sachs Group , Get Free , Gamunexc Immune Globulin Injection , Flebogamma Immune Globulin Intravenous , Xembify Immune Globulin Subcutaneous , Immune Globulin , Lynspad Alpha , Proteinase Inhibitor , Human Albumin , Plasbumin Albumin , Grifols Daily , Nasdaq Grfs ,

Grifols (NASDAQ:GRFS) Rating Lowered to Hold at StockNews.com

StockNews.com lowered shares of Grifols (NASDAQ:GRFS – Free Report) from a buy rating to a hold rating in a research note issued to investors on Tuesday morning. Separately, Morgan Stanley upgraded Grifols from an equal weight rating to an overweight rating in a research report on Wednesday, April 12th. Four equities research analysts have rated […] ....

United States , Nova Scotia , Albutein Flexbag , Vistaseal Veraseal , Us Bancorp , Morgan Stanley , Raymond James Associates , Blackrock Inc , Advisor Group Holdings Inc , Financial Services Group Inc , Grifols Company Profile , Free Report , Group Holdings , Services Group , Get Free Report , Gamunexc Immune Globulin Injection , Flebogamma Immune Globulin Intravenous , Xembify Immune Globulin Subcutaneous , Immune Globulin , Lynspad Alpha , Proteinase Inhibitor , Human Albumin , Plasbumin Albumin , Grifols Daily , Nasdaq Grfs , Stocknews Com ,